A man in his 90s presented to clinic with a conjunctival lesion on the right eye noticed two months prior. The patient denied pain but endorsed worsening blurry vision. The patient’s past medical history was significant for skin cancer on the right ear removed 3 years ago, and a history of ocular surface lesion removal on one eye approximately 20 years ago that was negative for any neoplasia. Slit lamp photograph revealed a gelatinous and opalescent lesion suspicious for ocular surface squamous neoplasia (OSSN) and the high-resolution optical coherence tomography (HROCT) cut (arrow)

Chemotherapy?induced neutropenia (CIN) can cause life-threatening complications such as febrile neutropenia (FN) or other infections. Patients who develop FN often require prolonged hospitalizations and treatment with broad-spectrum antibiotics.

Chemotherapy remains a cornerstone of modern cancer treatment, yet its neurotoxic side effects can pose significant challenges. Peripheral nerve damage and the resulting pain not only affect patients’ quality of life but also contribute to substantial economic burden. Despite the medical need, a definitive curative treatment for chemotherapy-induced peripheral neuropathy (CIPN) remains elusive, leaving many patients reliant on analgesics for pain relief. The QUCIP study, a prospective, multi-center observational study spanning 36 weeks, has recently yielded data evaluating the effectiveness of up to three treatments with high-concentration (179 mg) capsaicin patch (HCCP) in 73 female patients with painful CIPN following neoadjuvant/adjuvant breast cancer therapy.